The EP2 receptor has previously been shown to be epigenetically silenced in preferentially MYCN-amplified neuroblastoma tumors and cell lines, and therefore suggested to act as a tumor suppressor in aggressive neuroblastomas [20]. Here, MYCN is linked to neuroblastoma.